Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Latest CEO Comments

NOVEMBER 3, 2021

"Steady progression on our journey to build a broader and stronger Orexo"

Read the latest CEO comments from Nikolaj Sørensen

News flow

Regulatory Press Releases

Key financial figures

Group net revenue

580 MSEK
Last Twelve Months, Q420-Q321

Group EBITDA

-112 MSEK
Last Twelve Months, Q420-Q321

US Pharma segment EBIT

301 MSEK
Last Twelve Months, Q420-Q321

Cash position

588 MSEK
Q321
IR-Contact